Femme et Homme
- | Pays :
- Spain
- France
- United States
- ...
- | Organes : -
- | Spécialités : -
Extrait
This is a randomized, double-blind, placebo-controlled, multicenter phase 2 study of the safety and efficacy of 3-month subcutaneous (SC) REGN1033 (SAR391786) treatment in patients with sarcopenia.
Critère d'inclusion
- Sarcopenia